• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

CSL

Sanofi
Pharma

Sanofi offers commitments to end EU flu shot antitrust probe

Amid an EU probe into whether Sanofi “disparaged” one of its flu vaccine rivals, the French pharma has proposed several marketing changes.
Fraiser Kansteiner Jul 8, 2026 4:26pm
Sanofi

EC begins antitrust probe into Sanofi's flu shot campaign

Jun 26, 2026 11:20am
CSL Behring Kankakee Illinois site

CSL cuts FY26 revenue projection by $600M, writes off $5B

May 11, 2026 11:30am
topic report
drug prices biologics drug costs IRA money cash payment co-pay

Top 20 pharma companies by 2025 revenue

Apr 20, 2026 3:00am
CSL CSL Behring Kankakee Illinois

CSL firms up details on $1.5B US plasma-based medicines plant

Mar 10, 2026 10:30am
image of CSLs new RD facility

CSL details sales slide behind recent leadership transition

Feb 12, 2026 8:29am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings